Sukhtian Faisal Ghiath
SEC insider (Form 3/4/5 filer). CIK 0001716033. Director at Outlook Therapeutics, Inc. (OTLK). 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in ISELIN, NJ.
Companies Sukhtian Faisal Ghiath has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director
Sukhtian Faisal Ghiath
CIK: 0001716033
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Outlook Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 29, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseDirect95.4K shares at avg. $1.05$100K - May 27, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseDirect122.2K shares at avg. $0.41$50K - Oct 3, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
117.3K shares- - Oct 1, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
286.7K shares- - Feb 4, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
12.3K shares- - Oct 3, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19.8K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
134.4K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
56.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase | 95,398 | $1.05 | $99,996 | Direct |
| May 27, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase | 122,174 | $0.41 | $50,006 | Direct |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 117,296 | - | - | Direct |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 286,734 | - | - | Direct |
| Feb 4, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 12,323 | - | - | Direct |
| Oct 3, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,771 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 134,430 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 56,636 | - | - | Direct |
1-8 of 8 transactions